HPV vaccine implementation in STD clinics-STD surveillance network

Elissa Meites, Eloisa Llata, Susan Hariri, Jonathan Mark Zenilman, Lisa Longfellow, Jane Schwebke, Irina Tabidze, Christie Mettenbrink, Heidi Jenkins, Sarah Guerry, Preeti Pathela, Lenore Asbel, Jeffrey A. Stover, Kyle Bernstein, Roxanne P. Kerani, Eileen F. Dunne, Lauri E. Markowitz

Research output: Contribution to journalArticle

Abstract

We surveyed selected public sexually transmitted disease clinics in the United States regarding human papillomavirus vaccine availability, target populations, funding sources, and barriers. Although nearly all had experience offering other vaccines, only 7 of 42 clinics (17%) offered human papillomavirus vaccine. Vaccine cost, staff time, and follow-up issues were commonly reported barriers.

Original languageEnglish (US)
Pages (from-to)32-34
Number of pages3
JournalSexually Transmitted Diseases
Volume39
Issue number1
DOIs
StatePublished - Jan 2012

    Fingerprint

ASJC Scopus subject areas

  • Dermatology
  • Public Health, Environmental and Occupational Health
  • Microbiology (medical)
  • Infectious Diseases

Cite this

Meites, E., Llata, E., Hariri, S., Zenilman, J. M., Longfellow, L., Schwebke, J., Tabidze, I., Mettenbrink, C., Jenkins, H., Guerry, S., Pathela, P., Asbel, L., Stover, J. A., Bernstein, K., Kerani, R. P., Dunne, E. F., & Markowitz, L. E. (2012). HPV vaccine implementation in STD clinics-STD surveillance network. Sexually Transmitted Diseases, 39(1), 32-34. https://doi.org/10.1097/OLQ.0b013e3182315584